搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 1 日前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
Brewed awakening: can Blue Bottle’s instant coffee match the real thing?
South China Morning Post· 7 日前Two years ago, the brand entered the realm of instant espresso granules, which was billed as ...